Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.

AnaptysBio recorded $234 million in sales over the past four quarters.

The biotech group has struggled as a whole in 2025, but analysts say the innovation that has always supported the biotech ...

This biotech firm develops therapies for rare pulmonary diseases, leveraging proprietary drug delivery technology in the U.S.

Smaller biotech stocks often fly under the radar. Many of them aren't consistently profitable, but some can deliver outsize ...

Biotech ETFs can help investors capitalize on health care innovation while avoiding the boom-or-bust nature of individual ...

Corcept Therapeutics Inc. (NASDAQ: CORT) is one of the 10 best biotech stocks with highest upside potential.

Focused on immunology-based therapies for infectious diseases, this biotech company reported a notable insider sale in recent ...

Odyssey Therapeutics secured a valuation of $899.9 million after its ​shares rose 11.1% in their Nasdaq debut on Friday, ...

Following a turbulent year for the markets in general and biotech in particular, the industry made a notable recovery, ...

Now, it’s worth noting Stock Advisor’s total average return is 963% — a market-crushing outperformance compared to 201% for ...

Traws Pharma already develops antiviral drugs for influenza, H5N1 bird flu, and COVID-19. ・Hantavirus is a severe rodent-borne disease with a fatality rate of 30% to 50% in humans. ・The World Health ...